Novo Nordisk’s Biggest Shareholder Backs Italy Fund to Boost Drug Startups Beyond Denmark
2026-07-02 05:14:34
Novo Nordisk A/S’s biggest shareholder is investing in a new Italian startup accelerator as part of an effort to foster early-stage life science companies across Europe, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
OpenAI拟向美国政府提供5%股权
